Ubs Asset Management Americas Inc Mirum Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 149,518 shares of MIRM stock, worth $6.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,518
Previous 73,888
102.36%
Holding current value
$6.54 Million
Previous $3.06 Million
120.46%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$297 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$208 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$142 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$122 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$111 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.61B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...